The Phase II trial in Toronto, sponsored by a charity called the Remedy Institute, was issued a non-compliant rating on June 22, according to Health Canada. It's one of two active trials in the country.
Patient safety issues halt trial for MDMA-assisted psychotherapy during Health Canada review
Post a Comment